Stockholders’ Equity |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stockholders’ Equity | Note 8 – Stockholders’ Equity Movement in Common Stock
July 2025 Issuance of Common Stock Pursuant to Subscription Agreement On July 23, 2025, the Company issued 940,729 shares of common stock pursuant to subscription agreements entered into on May 12, 2025, for $17.74 per share. Total proceeds from this issuance was $16.7 million out of which $5.7 million was received in May 2025. The Company incurred $1.4 million in transaction expenses related to this issuance, out of which $0.4 million was incurred and recognized during the fiscal year ended June 30, 2025. July 2025 Issuance of Common Stock as Prepayment of Facility Fee On July 23, 2025, the Company issued 112,740 shares of Common Stock at a price of $19.41 per share to Macquarie Bank Limited as prepayment of facility fees that will become due under the Performance Bond Facility Agreement between Tamboran (West) Pty Limited, as borrower, Tamboran Resources Pty Ltd, as guarantor, and Macquarie Bank September 2025 Issuance of Common Stock as Termination Payment On July 28, 2025, the employment of Joel Riddle, the former Chief Executive Officer (“CEO”). and board member of the Company, was terminated and consequently Mr. Riddle resigned from the board of directors (the “Board”). The Company issued 50,000 shares of common stock at a price of $19.75 per share to Mr. Riddle as a part of his termination payment package. October 2025 Issuance of Common Stock under Public Offering On October 27, 2025, the Company issued 2,673,111 shares of common stock for $21.00 per share under a public offering. Total proceeds from the issuance was $56.1 million. The Company incurred $3.9 million in transaction expenses related to this issuance. November 2025 Share Purchase Plan On November 24, 2025, the Company issued 107,558,800 CDIs at a price of A$0.162 per CDI, the equivalent of 537,794 shares of common stock at a price of $20.93 per share, pursuant to the Share Purchase Plan opened by the Company on October 30, 2025. Total proceeds from the Share Purchase Plan was $11.3 million (A$17.4 million). December 2025 Issuance of Common Stock Against Vested Equity Awards On December 4, 2025, the Company issued 7,700,000 CDIs at a price of $0.109 per CDI the equivalent of 38,500 shares of common stock at a price of $21.73 per share upon the conversion of RSUs granted to certain eligible employees of the Group. On December 9, 2025, the Company issued 7,650 shares of common stock at a price of $21.73 per share upon conversion of RSUs granted to certain eligible employees of the Group. On December 12, 2025, the Company issued 2,309 shares of common stock at a price of $20.99 per share and 5,002 shares of common stock at a price of $19.99 per share upon conversion of RSUs granted to a member of the Board. On December 15, 2025, the Company issued 30,012 shares of common stock at a price of $19.99 per share upon conversion of RSUs granted to eligible directors, approved June 17, 2024.
|